| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DICE Therapeutics, Inc. | CMO | Common Stock | 0 | $46.50 | 09 Aug 2023 | Direct | |
| DICE Therapeutics, Inc. | CMO | Restricted Stock Units | 0 | 09 Aug 2023 | Direct | ||
| DICE Therapeutics, Inc. | CMO | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DICE | DICE Therapeutics, Inc. | 09 Aug 2023 | 7 | $0 | 4 | CMO | 09 Aug 2023, 16:26 |
| DICE | DICE Therapeutics, Inc. | 03 May 2023 | 1 | -$365,398 | 4 | CMO | 05 May 2023, 17:10 |
| DICE | DICE Therapeutics, Inc. | 27 Jan 2023 | 2 | $0 | 4 | CMO | 31 Jan 2023, 16:37 |
| DICE | DICE Therapeutics, Inc. | 14 Apr 2022 | 1 | $0 | 4 | CMO | 19 Apr 2022, 19:00 |
| DICE | DICE Therapeutics, Inc. | 14 Sep 2021 | 4 | $0 | 4 | CMO | 16 Sep 2021, 21:24 |
| DICE | DICE Therapeutics, Inc. | 14 Sep 2021 | 0 | $0 | 3 | CMO | 14 Sep 2021, 19:20 |